SOX9 is a dose-dependent metastatic fate determinant in melanoma
2019 · Journal of Experimental & Clinical Cancer Research · 42 citations
https://doi.org/10.1186/s13046-018-0998-6
X
Xintao Yang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
441
Citations
11
h-index
12
i10-index
Xintao Yang is an academic researcher from Beijing Institute of Technology. The author has contributed to research in topics: Cancer-related Molecular Pathways & Gastric Cancer Management and Outcomes & Ubiquitin and proteasome pathways. The author has an h-index of 11, co-authored 35 publications.
ORCID: 0000-0003-0364-9377Papers by this author
worksDEPDC1B Promotes Melanoma Angiogenesis and Metastasis through Sequestration of Ubiquitin Ligase CDC16 to Stabilize Secreted SCUBE3
2022 · Advanced Science · 23 citations
https://doi.org/10.1002/advs.202105226
CCL19-armed recombinant influenza virus inhibited colorectal cancer growth by remodeling tumor microenvironment
2025 · iScience · 1 citations
https://doi.org/10.1016/j.isci.2025.114127
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat